CD8A and neoplasm: A multifunctional immunoliposomes named CAT@aPDL1-SSLs promoted the delivery and accumulation of anti-PDL1 antibodies in tumor tissues to activate the infiltration of CD8+ T cells at the tumor site with low systemic toxicity (42).